Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;31(2):250-6.
doi: 10.1002/mds.26476. Epub 2016 Jan 22.

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings

Affiliations

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings

Charles H Adler et al. Mov Disord. 2016 Feb.

Abstract

Introduction: Finding a peripheral tissue biopsy site to diagnose early PD would be of value for clinical care, biomarker validation, and as research enrollment criteria. Whereas autopsy and advanced PD studies suggest that the submandibular gland is an important biopsy site, there are no studies in early PD. The aim of this study was to determine whether needle biopsy of the submandibular gland reveals Lewy type alpha-synucleinopathy in early PD.

Methods: Twenty-five early PD (duration < 5 years) and 10 controls underwent transcutaneous needle core biopsies of the submandibular gland. Tissue was stained for phosphorylated alpha-synuclein, reviewed blind to clinical diagnosis, and only nerve element staining was considered positive.

Results: Mean (standard deviation) age was 69.5 (8.3) for the PD group, 64.8 (8.0) years for controls, and disease duration 2.6 (1.1) years. Six PD and 1 control subject had inadequate glandular tissue. Positive staining was found in 14 of 19 (74%) PD and 2 of 9 (22%) control subjects. PD-positive and -negative cases did not differ clinically. Adverse events (mainly swelling and bruising) were common (77% of cases), but were minor and transient.

Conclusions: Submandibular gland needle biopsies identified phosphorylated alpha-synuclein staining in 74% of early PD subjects. False positives may be true false positives or may represent prodromal PD. If confirmed in larger studies with eventual autopsy confirmation, the potential value of submandibular gland biopsies for early PD may be to aid in clinical trial inclusion/exclusion and eventually serve as a gold standard for biomarker studies short of autopsy confirmation.

Keywords: Parkinson's disease; biopsy; submandibular gland; synuclein.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest for any author on this manuscript.

Figures

Figure 1
Figure 1
Flow sheets for the number of PD patients and Controls that had a submandibular gland biopsy and the biopsy results.
Figure 2
Figure 2. Photomicrographs of needle core tissue from submandibular gland biopsies of subjects with Parkinson’s disease
Section A was stained with hematoxylin and eosin. All other sections were stained with an immunohistochemical method for phosphorylated α-synuclein and then counterstained with Neutral Red (see Methods). A) Typical needle core. Arrow on left points to a region of glandular tissue while arrow on right points to an area of stromal connective tissue. B) Arrow points to an immunoreactive nerve fiber within a stromal nerve fascicle. Asterisks indicate non-specific immunoperoxidase staining of gland cell cytoplasm. C) Immunoreactive nerve fiber adjacent to two small blood vessels (two lower asterisks). A small duct is also close by (upper asterisk is within duct lumen). D) Several immunoreactive nerve fibers running in parallel within a stromal nerve fascicle. E) Immunoreactive nerve fibers (arrows) within a stromal nerve fascicle. F) Immunoreactive nerve fibers adjacent to a small duct. Asterisks indicate non-specific immunoperoxidase staining of gland cell cytoplasm. G) Immunoreactive nerve fiber (arrows) within a stromal nerve fascicle. H) Immunoreactive nerve fibers (arrows) adjacent to unstained glandular epithelial cells (asterisks).

References

    1. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta neuropathologica. 2010;119(6):689–702. - PMC - PubMed
    1. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord. 2012;27:717–719. - PubMed
    1. Shannon KM, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Mov Disord. 2012;27:709–715. - PubMed
    1. Visanji NP, Marras C, Kern DS, et al. Colonic mucosal alpha-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology. 2015;84:609–616. - PMC - PubMed
    1. Tolosa E, Vilas D. Peripheral synuclein tissue markers: a step closer to Parkinson’s disease diagnosis. Brain. 2015;138:2114–2152. - PubMed

Publication types

Substances